ACADIA Pharmaceuticals, Inc. (ACAD)
19.95
+0.06
(+0.30%)
USD |
NASDAQ |
Oct 02, 16:00
19.96
+0.01
(+0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals Profit Margin (Quarterly) : 10.23% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.23% |
| March 31, 2026 | 1.36% |
| December 31, 2025 | 96.33% |
| September 30, 2025 | 25.76% |
| June 30, 2025 | 10.08% |
| March 31, 2025 | 7.77% |
| December 31, 2024 | 55.37% |
| September 30, 2024 | 13.08% |
| June 30, 2024 | 13.80% |
| March 31, 2024 | 8.04% |
| December 31, 2023 | 19.82% |
| September 30, 2023 | -30.79% |
| June 30, 2023 | 0.67% |
| March 31, 2023 | -36.32% |
| December 31, 2022 | -30.57% |
| September 30, 2022 | -20.80% |
| June 30, 2022 | -25.28% |
| March 31, 2022 | -97.91% |
| December 31, 2021 | -32.96% |
| September 30, 2021 | -10.98% |
| June 30, 2021 | -38.08% |
| March 31, 2021 | -62.36% |
| December 31, 2020 | -55.17% |
| September 30, 2020 | -70.21% |
| June 30, 2020 | -38.27% |
| Date | Value |
|---|---|
| March 31, 2020 | -97.73% |
| December 31, 2019 | -53.94% |
| September 30, 2019 | -44.38% |
| June 30, 2019 | -66.03% |
| March 31, 2019 | -135.5% |
| December 31, 2018 | -109.9% |
| September 30, 2018 | -106.6% |
| June 30, 2018 | -110.9% |
| March 31, 2018 | -111.1% |
| December 31, 2017 | -158.1% |
| September 30, 2017 | -183.4% |
| June 30, 2017 | -221.3% |
| March 31, 2017 | -574.7% |
| December 31, 2016 | -657.9% |
| September 30, 2016 | -1.36K% |
| June 30, 2016 | -73.53K% |
| March 31, 2016 | -1.24M% |
| December 31, 2015 | -269.3K% |
| September 30, 2015 | -99.76K% |
| June 30, 2015 | -3.94M% |
| March 31, 2015 | -1.01M% |
| December 31, 2014 | -60.35K% |
| September 30, 2014 | -165.2K% |
| June 30, 2014 | -76.77K% |
| March 31, 2014 | -59.43K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | -225.1% |
| Biogen, Inc. | 3.72% |
| Insmed, Inc. | -3.11% |
| Arcutis Biotherapeutics, Inc. | 11.56% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 34.45% |
| Return on Assets | 25.47% |
| Return on Invested Capital | 32.75% |
| Gross Profit Margin (Quarterly) | 90.81% |
| Operating Margin (Quarterly) | 12.29% |
| Return on Net Operating Assets | 97.74% |